Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019)

Acro Biomedical (ACBM) has 2 years of Deferred Taxes data on record, last reported at -$73071.0 in Q3 2019.

  • For Q3 2019, Deferred Taxes changed N/A year-over-year to -$73071.0; the TTM value through Sep 2020 reached -$38017.0, down 110.32%, while the annual FY2019 figure was -$19941.0, N/A changed from the prior year.
  • Deferred Taxes reached -$73071.0 in Q3 2019 per ACBM's latest filing, down from -$10070.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $45124.0 in Q1 2019 and bottomed at -$73071.0 in Q3 2019.